IRIDESCENT

Serial Number 98661630
688

Registration Progress

Application Filed
Jul 23, 2024
Under Examination
Mar 4, 2025
Approved for Publication
Jan 7, 2025
Published for Opposition
Jan 7, 2025
Registered

Basic Information

Serial Number
98661630
Deadline
September 4, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
July 23, 2024
Published for Opposition
January 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 4, 2025
Application
Pending
Classes
042

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom
USPTO Deadlines 2 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Feb 06, 2025 151 days overdue Medium Until Mar 06, 2025
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Sep 04, 2025 59 days High Until Mar 04, 2026
Next deadline: Notice of Allowance Mailed - SOU Required on September 04, 2025 (59 days)

Application History

8 events
Date Code Type Description
Mar 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2024 DOCK D ASSIGNED TO EXAMINER
Jul 23, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Medical and scientific research in the field of oncology

Classification

International Classes
042